|11/14/17||Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia|
|PARSIPPANY, N.J., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that the U.S. Food and Drug Administration (FDA) has notified the company that its supplemental New Drug Application (sNDA) for EXPAREL® (bupivacaine liposome injectable suspension) as a nerve block for regional analgesia will be discussed at a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC). The meeting is tentatively scheduled for February 14-15, 2... |
|11/09/17||Pacira Pharmaceuticals to Present at Two November Healthcare Conferences|
|PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that members of its management team are scheduled to present at the following two healthcare conferences:
Jefferies 2017 Healthcare Conference in London, on Thursday, November 16, 2017 at 10:00 AM GMT (5:00 AM ET)
Piper Jaffray 29th Annual Healthcare Conference in New York City, on Wednesday, November 29, 2017 at 10:00 AM ET
A live audio webcast of the Pacira presentation... |
|11/08/17||Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results|
|EXPAREL(R) net product sales of $66.8 million up 3% over prior year third quarter; Full-year EXPAREL net product sales guidance revised to $280 to $285 million; Conference Call Today at 8:30 a.m. ET
PARSIPPANY, NJ -- (Marketwired) -- 11/08/17 --
Pacira Pharmaceuticals, Inc.
(NASDAQ: PCRX) today announced consolidated financial results for the third quarter ended September 30, 2017.
"We continue to make important progress during 2017 as we advance our strategy to expand the ro... |
|10/31/17||Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call|
|PARSIPPANY, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Wednesday November 8, 2017. The announcement will be followed by a conference call at 8:30 a.m. ET. Participating in the call from Pacira will be Dave Stack, chairman and chief executive officer, and other members of the company’s senior management team.
The call can be accessed by dialin... |